SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009499
Filing Date
2018-04-27
Accepted
2018-04-27 12:03:40
Documents
3
Period of Report
2018-06-12
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A mack-def14a_20180612.htm DEF 14A 1602976
2 GRAPHIC g2018042715314674823328.jpg GRAPHIC 57365
3 GRAPHIC g2018042715314677523329.jpg GRAPHIC 50353
  Complete submission text file 0001564590-18-009499.txt   1752674
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35409 | Film No.: 18782046
SIC: 2834 Pharmaceutical Preparations